日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Tissue Factor Bi-Specific T-Cell Engager Provides Effective Targeting and Cytotoxicity Against Cervical Cancer Cell Lines

一种组织因子双特异性T细胞衔接器可有效靶向并杀伤宫颈癌细胞系

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26188941
Lee, Kyung-Jun; Kim, Gilhyang; Seo, Booseong; Jeong, Soo Young; Kim, Hyeong Su; Cho, Hye-Yon; Park, Sung Taek
肿瘤
T细胞
肿瘤免疫
宫颈癌
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

CT83 Promotes Cancer Progression by Upregulation of PDL1 in Adenocarcinoma of the Cervix

CT83通过上调PD-L1促进宫颈腺癌的进展

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26062687
Kim, Gilhyang; Lee, Kyung-Jun; Shin, Eun; Park, Sung Taek; Kim, Hyeong Su; Cho, Hye-Yon
PD-L1
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Multiple Eruptive Epithelioid Hemangiomas on the Right Upper Extremity in an Asian Man

亚洲男性右上肢多发性爆发性上皮样血管瘤

期刊:
影响因子:
doi:10.5021/ad.21.221
Kim, Gilhyang; Kim, Jin Cheol; Kang, Seok Young; Kim, Hye One; Park, Chun Wook; Chung, Bo Young
发表日期：2023
文献求助 收藏

Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer

对用于检测POLE突变和子宫内膜癌分子分型的液滴数字PCR检测方法进行临床评价

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2022.33.e15
Kim, Gilhyang; Lee, Song Kook; Suh, Dong Hoon; Kim, Kidong; No, Jae Hong; Kim, Yong Beom; Kim, Hyojin
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Automated Diagnosis of Cervical Intraepithelial Neoplasia in Histology Images via Deep Learning

基于深度学习的宫颈上皮内瘤变组织学图像自动诊断

期刊:Diagnostics
影响因子:3.3
doi:10.3390/diagnostics12020548
Cho, Bum-Joo; Kim, Jeong-Won; Park, Jungkap; Kwon, Gui-Young; Hong, Mineui; Jang, Si-Hyong; Bang, Heejin; Kim, Gilhyang; Park, Sung-Taek
发表日期：2022
文献求助 收藏

Mucinous Cystadenoma of the Testis: A Case Report with Immunohistochemical Findings

睾丸黏液性囊腺瘤：一例免疫组织化学研究报告

期刊:Journal of Pathology and Translational Medicine
影响因子:3
doi:10.4132/jptm.2016.08.30
Kim, Gilhyang; Kwon, Dohee; Na, Hee Young; Kim, Sehui; Moon, Kyung Chul
IHC
免疫/内分泌
发表日期：2017
文献求助 收藏

Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma

FDA与ASCO/CAP标准在上尿路尿路上皮癌HER2免疫组化检测中的比较

期刊:Journal of Pathology and Translational Medicine
影响因子:3
doi:10.4132/jptm.2016.07.12
Kim, Gilhyang; Chung, Yul Ri; Kim, Bohyun; Song, Boram; Moon, Kyung Chul
肿瘤
IHC
HER2
肿瘤免疫
ASC
免疫/内分泌
发表日期：2016
文献求助 收藏